Advertisement
Organisation › Details
Fertin Pharma (Group)
Fertin Pharma is a privately held company with more than 850 employees and operations in Denmark, Canada, and India. It is a leading contract development and manufacturing organization (CDMO), specializing in the research, development and production of gums, pouches, liquefiable tablets, and other solid oral systems for the delivery of active ingredients, including nicotine, where it is a leading producer of Nicotine Replacement Therapy (NRT) solutions. The company and its employees bring significant scientific experience and know-how to the development of innovative solutions, driving above-category growth across new and existing business areas. In 2020, Fertin Pharma generated net revenues of DKK 1.1 billion (approximately USD 160 million). The transaction value represents a multiple of around 15 times Fertin Pharma’s 2020 EBITDA *
Start | 2021-07-01 existent | |
Industry | oral drug delivery technology | |
Person | Halling, Peter (Fertin Pharma 202107 CEO) | |
Region | Denmark_oo | |
Country | Denmark | |
City | n. a. | |
Address record changed: 2021-07-14 | ||
Basic data | Employees | E: 501 to 1,000 (2021-07-01) |
Currency | DKK | |
Annual sales | 1,100,000,000 (revenues, net, consolidated (2020) 2020-12-31) | |
* Document for »About Section«: Philip Morris International Inc.. (7/1/21). "Press Release: Philip Morris International Announces Agreement to Acquire Fertin Pharma". Lausanne. | ||
Record changed: 2024-02-12 |
Advertisement
More documents for Philip Morris (Group)
To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«
Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]
Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)
Advertisement
» top